Press release content from Business Wire. The AP news staff was not involved in its creation.
Prestige Biopharma’s New Vaccine Production Centre for Infectious Diseases Including COVID-19
April 20, 2021 GMT
New Prestige BioPharma vaccine centre in South Korea (Photo: Business Wire)
SINGAPORE (BUSINESS WIRE) Apr 20, 2021
Prestige Biopharma Limited (PBP), specializing in the development of antibody therapeutics, announces that the company will be introducing a vaccine development and production centre into its core business. PBP has been preparing for a business expansion into the development of vaccine-based therapeutics since the start of the ongoing COVID-19 outbreak as a response to the current, and potential future, viral pandemics. The design, development and implementation of the vaccine centre has resulted from that plan.